Propanc Biopharma annual capital expenditures (capex)
2011
2014
2015
2016
2019
Propanc Biopharma Capital Expenditures (CapEx) Growth & History (PPCB)
Propanc Biopharma's capital expenditures (capex) was $2,874 for fiscal 2019.
View full Propanc Biopharma company overviewPropanc Biopharma annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2019 | 2019-06-30 | $2,874 | — | — |
| 2016 | 2016-06-30 | $9,879 | $5,978 | +153.24% |
| 2015 | 2015-06-30 | $3,901 | $3,901 | — |
| 2014 | 2014-06-30 | $0 | — | — |
| 2011 | 2011-06-30 | $3,506 | — | — |
Propanc Biopharma quarterly capital expenditures (capex)
Q3.11
Q3.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.19
Q1.26
Q2.26
Q3.26
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q3 2026 | 2026-03-31 | $154 | — | — |
| Q2 2026 | 2025-12-31 | $2,267 | — | — |
| Q1 2026 | 2025-09-30 | $2,491 | — | — |
| Q3 2019 | 2019-03-31 | $1,212 | — | — |
| Q2 2017 | 2016-12-31 | $0 | −$3 | — |
| Q1 2017 | 2016-09-30 | $0 | −$679 | — |
| Q4 2016 | 2016-06-30 | $9,203 | $6,220 | +208.51% |
| Q3 2016 | 2016-03-31 | $0 | −$918 | — |
| Q2 2016 | 2015-12-31 | $3 | $3 | — |
| Q1 2016 | 2015-09-30 | $679 | $679 | — |
| Q4 2015 | 2015-06-30 | $2,983 | — | — |
| Q3 2015 | 2015-03-31 | $918 | $918 | — |
| Q2 2015 | 2014-12-31 | $0 | — | — |
| Q1 2015 | 2014-09-30 | $0 | — | — |
| Q3 2014 | 2014-03-31 | $0 | — | — |
| Q3 2011 | 2011-03-31 | $72 | — | — |
Propanc Biopharma capital expenditures (capex) trends
Over the last five fiscal years, Propanc Biopharma's capital expenditures (capex) increased from $0 to $2,874, a change of $2,874. The latest reported quarter, Q3 2026, shows $154.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Propanc Biopharma source filings ↗